首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Study of reactivity of cyanoacetohydrazonoethyl-N-ethyl-N-methyl benzenesulfonamide: preparation of novel anticancer and antimicrobial active heterocyclic benzenesulfonamide derivatives and their molecular docking against dihydrofolate reductase
【24h】

Study of reactivity of cyanoacetohydrazonoethyl-N-ethyl-N-methyl benzenesulfonamide: preparation of novel anticancer and antimicrobial active heterocyclic benzenesulfonamide derivatives and their molecular docking against dihydrofolate reductase

机译:氰基乙酰肼基乙基-N-乙基-N-甲基苯磺酰胺的反应性研究:新型抗癌和抗菌活性杂环苯磺酰胺衍生物的制备及其与二氢叶酸还原酶的分子对接

获取原文
获取原文并翻译 | 示例
           

摘要

This article describes the synthesis of some novel heterocyclic sulfonamides having biologically active thiophene 3, 4, 5, 6, coumarin 8, benzocoumarin 9, thiazole 7, piperidine 10, pyrrolidine 11, pyrazole 14 and pyridine 12, 13. Starting with 4-(1-(2-(2-cyanoacetyphydrazono)ethyl)-Nethyl-N-methylbenzenesulfonamide (2), which was prepared from condensation of acetophenone derivative 1 with 2-cyanoacetohydrazide. The structures of the newly synthesized compounds were confirmed by elemental analysis, IR, 'H NMR, 13C NMR, 19F NMR and MS spectral data. All the newly synthesized heterocyclic sulfonamides were evaluated as in-vitro anti-breast cancer cell line (MCF7) and as in-vitro antimicrobial agents. Compounds 8, 5 and 11 were more active than MTX reference drug and compounds 12, 7, 4, 14, 5 and 8 were highly potent against Klebsiella pneumonia. Molecular operating environment performed virtual screening using molecular docking studies of the synthesized compounds. The results indicated that some prepared compounds are suitable inhibitor against dihydrofolate reductase (DHFR) enzyme (PDBSD:4DFR) with further modification.
机译:本文介绍了一些具有生物活性噻吩3、4、5、6,香豆素8,苯并香豆素9,噻唑7,哌啶10,吡咯烷11,吡唑14和吡啶12、13的新型杂环磺酰胺的合成。从4-(苯乙酮衍生物1与2-氰基乙酰肼的缩合反应制得的1-(2-(2-氰基乙酰肼基)乙基)-N-N-甲基苯磺酰胺(2),通过元素分析,红外光谱确定了新合成的化合物的结构。 ,1H NMR,13C NMR,19F NMR和MS光谱数据。所有新合成的杂环磺酰胺均被评价为体外抗乳腺癌细胞系(MCF7)和体外抗微生物剂,化合物8、5和11它们比MTX参比药物具有更高的活性,化合物12、7、4、14、5和8对肺炎克雷伯菌具有很强的抗药性,并且通过分子对接研究对合成的化合物进行了分子操作环境的虚拟筛选。一些制备的化合物是经过进一步修饰的合适的二氢叶酸还原酶(DHFR)抑制剂(PDBSD:4DFR)抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号